The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions.
The post The Tariff Opportunity for Medtech: Building the Supply Chain of the Future appeared first on MedCity News.
